AFRICA – Roche and Jhpiego team up to help prevent or reduce the morbidity and mortality of women facing breast or cervical cancer in countries in Africa, taking a woman-centred approach.
In the upcoming phase two of the initiative, this partnership will build the capacity of primary and district facilities and put in place a networked patient continuum with navigation support for referrals, inclusive of lab referrals, minimizing loss to follow-up for women in Ghana to receive excellent cancer care.
This builds on a kickoff in Ghana in close collaboration with the Government of Ghana to foster an integrated, resource-stratified women’s cancer care continuum in support of the Ghana National Care and Control Plan.
Phase one of the project is serving as both stakeholder engagement and foundational groundwork for developing a cancer care framework and sustainable model.
BD to achieve cancer elimination
BD (Becton, Dickinson and Company) and the Ministry of Health Kenya will soon launch a pilot-for-scale oncology partnership aimed at providing end-to-end cervical cancer screening within the public sector. BD announces
This program will support Kenya to achieve cervical cancer elimination by 2030.
It will also create awareness at a community level, improve access to HPV screening, early diagnosis, and timely linkage to care in order to reach Kenyan leaderships’ goals to reach 90% of girls fully vaccinated with the HPV vaccine by age 15, 70% of women to be screened by 35 years of age, and 90% of women who are identified with pre-cancer or cancer to receive treatment.
US to support Access to Cervical Cancer Prevention
The President’s Emergency Plan for AIDS Relief (PEPFAR), implemented by the whole of U.S. government, is America’s commitment to fighting the global HIV and AIDS epidemic.
Since Fiscal year 2018, PEPFAR has invested over US$160 million in cervical cancer prevention among women living with HIV and integrates cervical cancer screening and treatment of pre-cancer as routine care for women with HIV infection under the Go Further Initiative, a collaboration with the George W. Bush Institute, Merck, Roche and the Joint United Nations Programme on HIV/AIDS (UNAIDS).
Through this work, the United States is dedicated to ending cervical cancer and AIDS and creating a healthier future for women across the continent of Africa.
Go Further invests in partner countries to raise awareness about cervical cancer by engaging and mobilizing communities of women affected by HIV, integrating and scaling up cervical cancer screening and treatment, and increasing access to modern technologies within existing HIV-treatment and women’s health programs.
To date, over 5.5 million cervical cancer screens have been conducted among women living with HIV since 2018, and over 200,000 have received treatment for pre-invasive cervical lesions.
For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.
